Thus, we sought to confirm that the enhanced RIPK2 and IL-17-promoting cytokine expression we observed in myeloid cells from CRC myeloid-miR-146a−/− mice (Figs. 2j, k) was due to the direct effect of miR-146a loss within these cell types. This evidence concerns the gene IL17A and colorectal carcinoma.